Trial Profile
A Phase 1 study of ONO-7056 in patients with solid tumor
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2019
Price :
$35
*
At a glance
- Drugs Salirasib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
- 02 Jun 2016 New trial record